BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year )

Similar documents
KOMAR UNIVERSITY OF SCIENCE AND TECHNOLOGY (KUST) Medical Bacteriology Syllabus (Theory) Spring 2016

MICROBIOLOGY BACTERIOLOGY III semester

Department of Microbiology, IMS, BHU Teaching schedule B.D.S. 4 th Semester 2 nd Year (2017 Batch) Session

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

HPSC - Weekly Infectious Disease Report

STUDY PLAN II year students 2nd semester 1 Class

THE KENYA POLYTECHNIC UNIVERSITY COLLEGE

Selected New Jersey Communicable Disease Regulations

Fort Detrick Area B11 Removal Action Update

Mechanisms of Pathogenicity

INFECTIOUS DISEASE. Page 2

Microbiology EQA Product Portfolio

M O L E C U L A R G E N E T I C S

Potential Reimbursement CPT Codes

SUMMER SEMESTER/ II nd ACADEMIC YEAR BACTERIOLOGY 4th semester FRIDAY. MICROBIOLOGY Lecture (Head Building) 11:00-12:30

V. A. Bacterial Diseases

Ministry of Social Affairs and Health, Finland N.B. Unofficial translation. Legally valid only in Finnish and Swedish

Rapid and progressive necrosis of the tissue underlying epidermis (cellulitis)

CHAPTER 515. COMMUNICABLE DISEASE AND INJURY REPORTING EFFECTIVE 9/12/2014

Bacterial Pathogenicity & Infections. Stijn van der Veen

SOUTH EASTERN KENYA UNIVERSITY UNIVERSITY EXAMINATION 2015/2016 FIRST SEMESTER EXAMINATION FOR THE DEGREE OF BACHELOR OF PUBLIC HEALTH

Section 1 has been repealed by Decree of 30 December 2003/1383.

SUPPLEMENTARY MATERIAL

Environmental Monitoring, risk assessment and responsibilities

FirstRanker.com. [KT 540] AUGUST 2008 Sub. Code : 4061

Normal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine

Fiscal Note for Permanent Rule Changes for North Carolina Division of Public Health

Cefotaxime Rationale for the EUCAST clinical breakpoints, version th September 2010

Cardiovascular Diseases. Dr. Hala Al- Daghistani

The German Law on Prevention and Control of Communicable Diseases (Infektionsschutzgesetz)- Surveillance System. Michael H. Kramer

Issued by: LABORATORY MANAGER Original Date: June 18, 2001 Approved by: Laboratory Director RESIDENT OBJECTIVES AT MSH

12/12/2011. Atypical Pneumonia. Objectives. Causative Agents of Acute Pneumonia Bacteria. Causative Agents of Acute Pneumonia Other Agents

Microsan rx Anti-Microbial Healthcare Professional Soap. Organism Positives ATCC #

Microbes as Agents of Infectious Disease

Cefuroxime iv Rationale for the EUCAST clinical breakpoints, version th September 2010

Interstate Shipment of Etiologic Agents 42 CFR Part 72

स क ष मज व ववज ञ न ववभ ग DEPARTMENT OF MICROBIOLOGY व.एम.एम.स ए व सफदरज ग अस पत ल VMMC & SAFDARJUNG HOSPITAL नई ददल ल ११००२९ NEW DELHI

Treatment of febrile neutropenia in patients with neoplasia

"Wanted Poster" Diseases

List of teams: Practice question: Which of the following individuals was among the first to recognize the importance of handwashing?

SCOTT COUNTY DAY CARE PROVIDER POLICY

Amoxitid 125 Suspension Each teaspoonful (5 ml) contains Amoxicillin (as trihydrate) 125 mg.

CLINICAL MICROBIOLOGY AND IMMUNOLOGY. Microbial Mechanisms of Pathogenicity

Storage conditions. roomtemperature or incubator at 36 C. Other: 2-8 C Blood: roomtemperature or incubator at. A.s.a.p. max 24h. A.s.a.p.

MICROBIOLOGY - An Overview

Scheme Description. Clinical Microbiology Laboratory Scheme

TOUCAN DATA & SCIENCE INFORMATION

Division of Studies in English (2/6MD winter semester, 2017/2018) MICROBIOLOGY OUTLINE

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

Microbes as Agents of Infectious Disease

Veterinary Bacteriology and Mycology

Microbiology Specimen Collection Instructions. Table I Culture and Sensitivities/TB

Bio Microbiology - Spring 2013 Study Guide 20 Normal Flora - Normal Responses - Disease

ZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg

Cal OSHA Title 8, Section 5199 Appendix D: Aerosol Transmissible Pathogens Laboratory

Anaerobic bacteria and more. Stijn van der Veen

KENNEL KARE SC DISINFECTANT / CLEANER / DEODORIZER Efficacy Data EPA Reg. #

Report on the Performance of the. VidaShield System

Burton's Microbiology for the Health Sciences

Course Specification of Microbiology and Immunology for master of HepatobillarySurgery A- Administrative Information Course Title: Microbiology and

LIST OF QUESTIONS FOR MODULE 2 and 3 MEDICAL MICROBIOLOGY AND VIROLOGY

Work up of Respiratory & Wound Cultures:

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

A guide to pathogenic bacteria

PEACEHEALTH LABORATORIES

Infection Data: Form Updates

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Pathogen Matrix PATHOGEN CLAIM PPM (MG/L) / ORP TIME (MIN) DETAILS SOURCE

Syndromic Testing: The right test, the first time.

Block DRAFT 17 (Revised )

4. The most common cause of traveller s diarrheoa is a. Rotavirus b. E coli c. Shigella d. Giardia e. Salmonella

PATHOGEN DETECTION WITH THE FILMARRAY

New Mexico Emerging Infections Program Overview. Joan Baumbach NM Department of Health September 23, 2016

MONTGOMERY COUNTY COMMUNITY COLLEGE Department of Science BIO 140 Lecture Outline Chapters 21, 22 and 23

Publications of the National Public Health Institute KTL B 10/2001. Infectious diseases in Finland 2000

Beta-lactamase production should have no effect on Azithromycin activity.

Notes from the Sentinel Liaison

MICROBIOLOGY , III semester BACTERIOLOGY

Consultation on the Revision of Carbapenem Breakpoints

35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough

MEASLES MUMPS PERTUSSIS HEPATITIS A HEPATITIS B HEPATITIS C HAEMOPHILUS INFLUENZAE (INVASIVE DISEASE)...

Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)

MICROBE FLORA AND ORAL MICRIFLORAS. Prof. Dr. Tamer ŞANLIDAĞ

Beta-lactamase production should have no effect on Azithromycin activity.

DEMIS Deutsches elektronisches Meldesystem für den Infektionsschutz (German electronic reporting system for infectious diseases control)

DIVISION OF ANTIINFECTIVE DRUG PRODUCTS (HFD-520) CLINICAL MICROBIOLOGY REVIEW NDA Date review completed: 15 Jun 05

Ceftomax TM S (Cefoperazone Sodium plus Sulbactam Sodium Injection)

Class 15. Infections of the Central Nervous System

1. Which of the following statements concerning Plasmodium vivax is TRUE?

M E D I C A L L A B O R A T O R Y

HYPOCHLOROUS ACID (HOCl) Our Body's immune system protector in a BOTTLE

Lecture 3. Microbial Physiology

Cell counting (EtBr) Before cell-lysis. Cell-lysis by 3% SDS beads beating. After cell-lysis

Streptococci facultative anaerobe

Pathogen Reduction/Inactivation KABB Annual Meeting Elpidio Pena, MD, MA Norton Healthcare Transfusion Services

Transcription:

BACTERIOLOGY PROGRAMME AND PLAN OF TEACHING 3 rd Semester (academic year 2012-2013) 19. 10. 2012. Introduction in microbiology, bacterial taxonomy, general bacterial prop Bacterial structures, biosynthesis and organization of bacterial cell (spore, flagelum, capsule, cell wall). Pathogenicity and virulence. Normal bacterial flora (colonization, primary sterile regions, composition and significance of normal flora). Carrier state and bacterial infection. 26. 10. 2012. Bacterial metabolism; nutrition requirements for growth and replication of bacteria. Sterilization, control of sterilization, disinfection. Practical lesson 2 lessons Specimen collection (examination of specimen from different organ systems). Specimen transport (package and labeling). 02. 11. 2012. Bacterial genetic material; genetic exchange in bacteria: transformation, conjugation and transduction. Practical lesson 2 lessons Microscopic examination of morphological and structural components of bacterial cell (wet mounts, Metylene blue stain, Gram stain). 09. 11. 2012. Virulence factor of bacteria (adhesive factors, invasive factors, toxins). + Methods for bacterial isolation and identification. 16. 11. 2012. Mechanism of action of antibacterial agents. Bacterial resistance to antibacterial agents. Antimicrobial susceptibility testing (disc diffusion method, broth dillution method and E test). 1

23. 11. 2012. Microorganisms and their products in food, water and enviroment; diseases caused by these microorganisms. General properties of genus Streptococcus, characteristics and medical imortance of Streptococcus pyogenes. Methods for rapid diagnosis of bacterial infections. Serologic tests in diagnosis of bacterial infections. 30.11. 2011. Properties and medical imortance of Streptococcus pneumoniae, Streptococcus agalactiae and viridans streptococci. General properties and medical importance of genus Enterococcus. General properties of genus Neisseria; characteristics and medical imortance of Neisseria gonorrhoeae and Neisseria meningitidis Laboratory diagnosis of infections caused by genus Streptococcus and genus Enterococcus. 07. 12. 2011. General properties of genus Staphylococcus; characteristics and medical imortance of Staphylococcus aureus; properties and medical imortance of coagulase negative staphylococci (Staphylococcus epidermidis, Staphylococcus saprophyticus) and biofim production. Laboratory diagnosis of infections caused by genus Staphylococcus and genus Neisseria. 14. 12. 2012. General properties of familly Enterobacteriacea; characteristics and medical imortance of opportunistic enterobacteria (Enterobacter, Klebsiella, Serratia, Proteus), characteristics and medical imortance of genus Yersinia and species Yersinia enterocolitica. Characteristics and medical imortance of Escherichia coli. Characteristics and medical imortance of genus Salmonella and genus Shigella. General properties and medical imortance genus Corynebacterium; characteristics and medical imortance of Corynebacterium diphtheriae and diphtheroids. 2

21.12.2012. General properties of genus Mycobacterium; characteristics and medical imortance of Mycobacterium tuberculosis complex; characteristics and medical imortance of Mycobacterium leprae and opportunistics mycobacteria. Laboratory diagnosis of infections caused by enterobacteria. 28. 12. 2011. General properties and medical imortance of Gram negative nonfermentative bacteria; characteristics and medical imortance of Pseudomonas aeruginosa, Acinetobacter spp. and Stenotrophomonas maltophilia. General properties and medical imortance of asporogenic anaerobic bacteria; characteristics and medical imortance of genus Bacteroides and genus Propionibacterium. Laboratory diagnosis of infections caused by genus Mycobacterium. 11.01. 2013. General properties of genus Clostridium; characteristics and medical imortance of Clostridium difficile, Clostridium perfringens and other causative agents of clostridial mionecrosis. General properties and medical imortance of Clostridium tetani and Clostridium botulinum. Practical lesson - 1 lesson Laboratory diagnosis of infections caused by Gram negative nonfermentative bacteria. General properties and medical imortance of Listeria monocytogenes 18.01. 2013. General properties and medical imortance of genus Chlamydia, Chlamydophila, Mycoplasma, Ureaplasma. Practical lesson - 1 lesson Laboratory diagnosis of infections caused by anaerobic sporeforming and non-sporeforming bacteria. Practical lesson - 1 lesson Laboratory diagnosis of infections caused by strictly intracellular bacteria and mycoplasma. 3

25. 01. 2013. Medical importance of zoonotic bacteria, general properties and medical imortance of genus Brucella and genus Francisella. General properties and medical imortance of genus Rickettsia, Bartonella, Erhlichia, and bacteria Coxiella burnetii. General properties and medical imortance of genus Bacillus; characteristics and medical imortance of Bacillus anthracis i Bacillus cereus. General properties and medical imortance of Yersinia pestis. 01. 02. 2013. General properties and medical imortance of Haemophilus influenzae and Bordetella pertussis General properties and medical imortance of Legionella pneumophila, Campylobacter jejuni and Helicobacter pylori. BACTERIOLOGY IV semester 22. 02. 2013. General properties and medical imortance of spirochetes, characteristics and medical imortance of Borrelia burgdorferi and Leptospira interrogans. Characteristics and medical imortance of Treponema pallidum 01. 03. 2012. General properties and medical imortance of Vibrio, characteristics and medical imortance of Vibrio cholerae. Bacterial vaccines. 4

08. 03. 2012. Aktuelni bakterijski patogeni I: multirezistentni sojevi bakterija (MRSA, VRE, multirezistentne enterične bakterije, multirezistentne Gram negativne nefermentujuće bakterije, multirezistentni i ekstenzivno rezistentni Mycobacterium tuberculosis). Aktuelni bakterijski patogeni II: oportunističke bakterije (koagulaza negativne stafilokoke, Clostridium difficile, netuberkulozne mikobakterije, Rhodococcus equi i druge). Microbiology Course Director Professor Maja Ćupić 5

Important informations and rules on subject: MICROBIOLOGY 2 nd Academic year 2012/13 Course in Microbiology consists of three teaching areas: Bacteriology, Virology and Parasitology with Mycology. Class attendance is obliged, and only in the term schedule. This allows for a maximum of 2 absences from seminars / exercises without compensation per semester, but in summer semester absences must be from different areas. The final MARK from subject Microbiology is formed as follows: 30% of pre-exam assessment activities (colloquiums and evaluation activities) 20% practical exam grades 50% final test Pre-Exam Activities include taking colloquiums and evaluation of students' activities during school hours. Each colloquiums in the final evaluation carry maximum 20%, and student activities from a maximum of 10%. Colloquiums During the school year, there are two colloquiums: the end of the winter semester - Microbiology I and second at the end of the summer semester colloquium- Microbiology II. The maximum number of points that a student can win the Colloquium I was 35, and also the 35th Colloquium II. For each test shall be organized into two terms. Obliged to go out in the first period, while the second output only students who have failed the test in the first term and those who receive the approval of the Department on the basis of medical justification for the absence of the first term tests. Passed the colloquium where students achieve at least 51% of the maximum number of points. Failed the colloquium (0-50% points) does not carry points in the final rating and is calculated as 0. To exit the practical and final examination the student is NOT required to have passed a preliminary exams (regardless of the obligation on them to come). Passed the test is valid for 2 academic years. EVALUATION ACTIVITIES student during school carries so reward points. The maximum number of points in this way they can win is 35 as follows: Area points: Bacteriology 17 Virology 9 Parasitology with Mycology 9 TOTAL 35

Therefore, the total number of points with pre-exam activities that can achieve the maximum is 105, and the students who thus win 85 or more points, RELEASE the practical part of the examination in the academic year in which they listen to classes. Thus passed the skill test carries a maximum of 20% of the final grade. PRACTICAL exam are taken in the form of a CONVERSATION. Passed the practical exam, except for a period in which the pass is valid even following the exams (a total of three test periods). MARK ON FINAL TEST in MICROBIOLOGY II Academy year 2011/12 Total number of questions/points on Final Test in Microbiology are 100: 50 Bacteriology 26 Virology 24 Parasitology with Micology Half from total number of points 51 is needed for passing. It is neccessary to have minimum points from each fields: 25 from Bacteriology 13 from Virology 13 from Parasitology with Micology 51-61 6 (six) 62-71 7 (seven) 72-81 8 (eigh) 82-91 9 (nine) 92-100 10 (ten) Final Mark represents SUM of SCORE/MARK from Pre-Exam Activities (Colloquiums and Students activities), Practical Exam and Final Test Microbiology Course Director Professor Maja Ćupić